Edition:
United Kingdom

ProQR Therapeutics NV (PRQR.OQ)

PRQR.OQ on NASDAQ Stock Exchange Global Market

17.47USD
15 Oct 2018
Change (% chg)

-- (--)
Prev Close
$17.47
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
61,634
52-wk High
$22.85
52-wk Low
$2.78

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.97 -0.230
Mar '18 0.50 -0.334
FY 2017 Dec '17 0.51 -0.393
Sep '17 0.33 -0.416
Jun '17 0.26 -0.474
Mar '17 0.39 -0.446
FY 2016 Dec '16 0.10 -0.378
Sep '16 0.45 -0.434
Jun '16 0.59 -0.427
Mar '16 0.69 -0.437
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 0.88 1.03 0.60 --
Quarter Ending Mar-19 1 1.60 1.60 1.60 --
Year Ending Dec-18 4 2.93 3.70 2.00 0.56
Year Ending Dec-19 4 3.03 4.91 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 3 -0.36 -0.27 -0.53 --
Quarter Ending Mar-19 1 -0.29 -0.29 -0.29 --
Year Ending Dec-18 3 -1.36 -1.21 -1.63 -1.74
Year Ending Dec-19 4 -1.78 -1.27 -2.38 -1.80
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 86.20 32.69
P/E High - Last 5 Yrs. -- 290.01 45.21
P/E Low - Last 5 Yrs. -- 90.56 23.82
Beta -- 0.93 0.88
Price to Sales (TTM) 79.24 123.88 5.82
Price to Book (MRQ) 2.60 15.34 4.90
Price to Tangible Book (MRQ) 2.61 14.54 6.53
Price to Cash Flow (TTM) -- 70.75 22.98
% Owned Institutions 54.62 13.94 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.34 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.56 5.38
Payout Ratio(TTM) -- 16.91 43.96

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -55.01 391.55 7.73
Sales (TTM) vs TTM 1 Yr. Ago -64.75 73.89 5.32
Sales - 5 Yr. Growth Rate -- 30.83 9.89
EPS (MRQ) vs Qtr. 1 Yr. Ago -11.03 24.83 22.57
EPS (TTM) vs TTM 1 Yr. Ago -24.00 -- --
EPS - 5 Yr. Growth Rate -- 37.95 10.95
Capital Spending - 5 Yr. Growth Rate -- 38.70 14.94

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.94 2.25
Current Ratio (MRQ) 8.22 5.32 3.05
LT Debt to Equity (MRQ) 16.54 35.04 12.63
Total Debt to Equity (MRQ) 16.54 36.85 16.96
Interest Coverage (TTM) -- -97.99 37.54

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.92
Gross Margin - 5 Yr. Avg. -- 49.23 52.45
EBITD Margin (TTM) -3,241.64 -- --
EBITD - 5 Yr. Avg -- -574.53 11.10
Operating Margin (TTM) -3,331.95 -770.03 4.36
Operating Margin - 5 Yr. Avg. -- -594.78 6.45
Pre-Tax Margin (TTM) -3,376.41 -731.81 5.41
Pre-Tax Margin - 5 Yr. Avg. -- -600.11 6.89
Net Profit Margin (TTM) -3,376.57 -732.73 1.68
Net Profit Margin - 5 Yr. Avg. -- -603.07 3.14
Effective Tax Rate (TTM) -- 23.70 23.23
Effective Tax Rate - 5 Yr. Avg. -- 18.84 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 10,657 22,887,281 812,879,200
Net Income/Employee (TTM) -359,831 1,727,321 95,609,515
Receivable Turnover (TTM) -- 19.88 5.78
Inventory Turnover (TTM) -- 2.39 3.60
Asset Turnover (TTM) 0.02 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -61.65 -0.96 10.94
Return on Assets - 5 Yr. Avg. -- 3.30 12.05
Return on Investment (TTM) -68.51 0.73 14.32
Return on Investment - 5 Yr. Avg. -- 2.37 15.66
Return on Equity (TTM) -75.74 1.82 16.04
Return on Equity - 5 Yr. Avg. -- 3.23 16.92
  1 Year 3 Year 5 Year
Sales % -43.49 150.71 --
EPS (TTM) % -87.68 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ProQR Therapeutics NV

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 45.29%
# of Holders: 37
Total Shares Held: 17,068,856
3 Mo. Net Change: 1,877,999
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 1
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.